DYSPORT

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug DYSPORT contains one active pharmaceutical ingredient (API):

1 Botulinum type A toxin haemagglutinin complex UNII E211KPY694 - BOTULINUM TOXIN TYPE A

Botulinum toxin type A is a protein complex derived from Clostridium botulinum. The protein consists of type A neurotoxin and several other proteins. Under physiological conditions it is presumed that the complex dissociates and releases the pure neurotoxin. Intramuscular injection of the neurotoxin complex blocks cholinergic transport at the neuromuscular junction by preventing the release of acetylcholine. The nerve endings of the neuromuscular junction no longer respond to nerve impulses and secretion of the chemotransmitter is prevented (chemical denervation). Read about Botulinum toxin type A

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M03AX01	Botulinum toxin	M Musculo-skeletal system → M03 Muscle relaxants → M03A Muscle relaxants, peripherally acting agents → M03AX Other muscle relaxants, peripherally acting agents
Discover more medicines within M03AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10981Y, 10982B, 10987G, 10988H, 11006G, 11007H, 11015R, 11022D, 11831Q, 11857C, 12178Y, 12214W
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 539200201155412, 539212040000403
Country: CA	Health Products and Food Branch	Identifier(s): 02387735, 02456117, 02460203
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 26.634-10-05, 97-MBE-0417
Country: EE	Ravimiamet	Identifier(s): 1040386, 1074305, 1557907, 1557918
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 61155
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 017962, 048623, 481598
Country: FR	Base de données publique des médicaments	Identifier(s): 60242321, 61717276
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 185389, 47849
Country: HK	Department of Health Drug Office	Identifier(s): 36983
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6720, 7955
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1018160, 1018161, 1060897, 1060898, 1069679, 1070907, 1078855, 1087895, 1088159, 1092397, 1092398, 1093212, 1093213
Country: MT	Medicines Authority	Identifier(s): AA770/13301
Country: NL	Z-Index G-Standaard	Identifier(s): 14338343, 15861473
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 105341, 40916
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 16053, 6423
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100201557, 100300638
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65098001
Country: SG	Health Sciences Authority	Identifier(s): 10954P, 15238P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 4243012H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699783790110
Country: US	FDA, National Drug Code	Identifier(s): 0299-5962, 15054-0500, 15054-0530
Country: ZA	Health Products Regulatory Authority	Identifier(s): 37/30.4/0683